IR-Med Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Ran Ziskind

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	less than a year
CEO sahipliği	n/a
Yönetim ortalama görev süresi	3.6yrs
Yönetim Kurulu ortalama görev süresi	3.9yrs

Son yönetim güncellemeleri

Recent updates

CEO

Ran Ziskind

less than a year

Görev süresi

Mr. Ran Ziskind is Chief Executive Officer of IR-Med Inc. from September 1, 2024. Mr. Ziskind is a highly experienced high-tech innovator and company leader with two decades of expertise in launching, deve...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Oded Bashan	Co-Founder & Chairman	11.2yrs	US$273.73k	12.13% $ 7.1m
Aharon Klein	Co-Founder	11.2yrs	US$101.07k	11.07% $ 6.5m
Aharon Binur	Chief Development Officer	3.6yrs	US$252.67k	0% $ 0
Ran Ziskind	Chief Executive Officer	less than a year	Veri yok	Veri yok
Yaniv Cohen	Co-Founder	1.8yrs	Veri yok	11.07% $ 6.5m
Sharon Levkoviz	CFO, Treasurer & Secretary	3.9yrs	Veri yok	0% $ 0
Avi Vachnis	Head of Software & AI	3.3yrs	Veri yok	Veri yok

3.6yrs

Ortalama Görev Süresi

60yo

Ortalama Yaş

Deneyimli Yönetim: IRME 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.6 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Oded Bashan	Co-Founder & Chairman	11.2yrs	US$273.73k	12.13% $ 7.1m
Aharon Klein	Co-Founder	11.2yrs	US$101.07k	11.07% $ 6.5m
Yaniv Cohen	Co-Founder	3.9yrs	Veri yok	11.07% $ 6.5m
Ohad Bashan	Director	3.9yrs	Veri yok	0% $ 0
Richard Serbin	Member of Advisory Board	1.2yrs	Veri yok	Veri yok
Ron Mayron	Independent Director	3.9yrs	US$78.50k	0% $ 0
David Levy	Director of IR-Med Ltd	9.8yrs	Veri yok	Veri yok
Lynn Eschenbacher	Member of Advisory Board	no data	Veri yok	Veri yok
Avital Rosenberg	Independent Director	less than a year	Veri yok	Veri yok

3.9yrs

Ortalama Görev Süresi

62yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: IRME 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.9 yıldır).

IR-Med Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

IR-Med Inc. Announces Chief Executive Officer Changes

IR-Med Inc. Appoints Avital Rosenberg as A Class I Director and Member of the Audit Committee

IR-Med Inc., Annual General Meeting, Nov 07, 2023

IR-MED Announces Executive Changes Effective as of October 15, 2023

IR-Med Inc. Appoints Richard Serbin, Esq. to Its Advisory Board

IR-Med Inc. Appoints Lynn Eschenbacher to its Advisory Board

Recent updates

IR-Med Inc. Announces Chief Executive Officer Changes

IR-Med Inc. Receives $500,000 Grant from the Israel Innovation Authority to Develop its Platform Technology for the Early Detection of Diabetic Foot Ulcers

IR-Med Inc. has filed an IPO in the amount of $8 million.

IR-Med Inc. Appoints Avital Rosenberg as A Class I Director and Member of the Audit Committee

IR-Med Inc.’s PressureSafe Reduced Pressure Injuries by 50% During a Usability Study with Clalit, Israel’s Hmo

IR-Med Inc.'S PressureSafe Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries

IR-MED to Report New Clinical Efficacy Data for Detection of Pressure Injuries with its AI- Based PressureSafe™ Device at NPIAP 2024 Annual Conference on February 16

IR-Med Inc., Annual General Meeting, Nov 07, 2023

IR-MED Announces Executive Changes Effective as of October 15, 2023

Ir-Med to Conduct Usability Study with Methodist Healthcare of San Antonio for Its Pressuresafe Device Which Is Slated for U.S. Launch in H1 2024

IR-Med Inc. Appoints Richard Serbin, Esq. to Its Advisory Board

Ir-Med Inc. Announces Interim Results from A Clinical Study of Pressuresafe

IR-Med Inc. Appoints Lynn Eschenbacher to its Advisory Board

IR-Med Inc., Annual General Meeting, Dec 12, 2022

IR-Med Announces Appointment of Moshe Gerber as Chief Executive Officer

International Display Advertising, Inc. (OTCPK:IDAD.D) completed the acquisition of IR Med, Ltd.

International Display Advertising, Inc. announced that it expects to receive $5 million in funding

CEO

Görev süresi

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş